Advancing Access to Patient Care: The Importance of Advocacy on the Hill
AdvaMed’s 2024 Medtech Showcase on Capitol Hill featured 37 companies and 40+ innovations, connecting medtech leaders with U.S. policymakers.
Medtech POV Blog
AdvaMed®’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
Filter By:
Why You Can’t Miss #MTC25
Join thousands of industry leaders October 5-8, 2025, in San Diego, California for direct access to hundreds of hours of timely medtech education, networking with industry leaders and CEOs, and…
Medtech Goes to Capitol Hill
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…
Medtech is Essential: Industry Supports Call for Tariff Flexibility
AdvaMed® President and CEO Scott Whitaker testified before the U.S. Senate Finance Committee, bringing attention to the pressing issue of how tariffs could impact the medtech industry and, most importantly,…
Listen to AdvaMed®'s Podcast
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Orthogonal, Kwame Ulmer on the Value ofAdvaMed® Membership
AtAdvaMed®, we’re proud to be recognized for our work on behalf of the medtech community – and we’re especially grateful when that recognition comes from respected voices like Kwame Ulmer…
THE Medtech Event of the Year
Join thousands of industry leaders October 5-8, 2025, in San Diego, California for direct access to hundreds of hours of timely medtech education, networking with industry leaders and CEOs, and…
Centering the Patient Voice in Medtech Innovation
AdvaMed® President and CEO Scott Whitaker describes the importance of engaging patients in every stage of medtech innovation.
Why Lifesaving Medtech Should Be Tariff-free: An Interview with AdvaMed’s CEO
AdvaMed® President and CEO Scott Whitaker is leading the call for a reciprocal “zero-for-zero” tariff agreement on medtech, urging the U.S. and its trading partners to eliminate tariffs on essential,…
Press Contact
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
Why the Administration Should Be Flexible with Medtech Tariffs to Protect Patients and Innovation
Flexibility on tariffs is critical to maintaining medtech as the backbone of the U.S. health care system and an American economic success story.
Become an AdvaMed® Member
Join over 500 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.